Get the Stockscreener App
17.62
2.26%
0.39
After Hours:
17.62
Cellebrite Di Ltd Stock (CLBT) Forecast
The Cellebrite Di Ltd (CLBT) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $5.2028, representing a -70.47% decrease from the current price of $17.62. The highest analyst price target is $5.6527, and the lowest is $4.7529.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CLBT Price Target
Average 5.8244
(-66.94% Downside)
Is Cellebrite Di Ltd (CLBT) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 34.77 | Neutral |
| STOCH(9,6) | 28.03 | Neutral |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | -1.3762 | Sell |
| ADX(14) | 45.04 | Sell |
| William %R | -58.39 | Neutral |
| CCI(14) | -13.33 | Neutral |
Buy: 0
Sell: 3
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
17.85
Sell
|
17.95
Sell
|
| MA20 |
19.00
Sell
|
19.05
Sell
|
| MA50 |
21.60
Sell
|
20.39
Sell
|
| MA100 |
20.53
Sell
|
19.94
Sell
|
| MA200 |
17.41
Buy
|
17.78
Sell
|
Buy: 1
Sell: 9
Neutral: 0
Summary: Sell
According to our latest analysis, CLBT could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 12 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on CLBT, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 34.77 indicates that CLBT is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 28.03 indicates that CLBT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that CLBT is oversold. This suggests that CLBT price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 45.04 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -13.33 indicates that CLBT is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term CLBT price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Cellebrite Di Ltd financial reports and earnings history, Cellebrite Di Ltd (CLBT) stock could reach $12.05 by 2030, $6.4741 by 2040 and $15.27 by 2050. See the projected annual prices until 2050 of the Cellebrite Di Ltd stock below:
- Cellebrite Di Ltd (CLBT) is expected to reach an average price of $9.1053 in 2035, with a high prediction of $9.5113 and a low estimate of $8.571. This indicates an $-48.32% rise from the last recorded price of $17.62.
- Cellebrite Di Ltd (CLBT) stock is projected to chart a bullish course in 2040, with an average price target of $6.2741, representing an $-64.39% surge from its current level. The forecast ranges from a conservative $5.7838 to a sky-high $6.4741.
- Our analysts predict Cellebrite Di Ltd (CLBT) to jump -57.01% by 2045, soaring from $6.5142 to an average price of $7.5742, potentially reaching $8.2029. While $6.5142 is the low estimate, the potential upside is significant.
- Cellebrite Di Ltd (CLBT) stock is expected to climb by 2050, reaching an average of $14.29, a $-18.88% jump from its current level. However, a wide range of estimates exists, with high and low targets of $15.27 and $14.02, respectively, highlighting the market's uncertainty.
Cellebrite Di Ltd Stock (CLBT) Year by Year Forecast
Cellebrite Di Ltd Stock (CLBT) Price Forecast for 2025
Cellebrite Di Ltd Stock (CLBT) is expected to reach an average price of $5.3164 in 2025, with a high prediction of $6.5297 and a low estimate of $4.1032. This indicates an -69.83% fall from the last recorded price of $17.62.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| April, 2025 | $4.8729 | $4.7529 | $5.6527 | -72.34% |
| May, 2025 | $4.6232 | $4.1032 | $5.053 | -73.76% |
| June, 2025 | $5.1334 | $4.2448 | $5.1934 | -70.87% |
| July, 2025 | $4.8237 | $4.6034 | $5.2636 | -72.62% |
| August, 2025 | $4.4839 | $4.3538 | $5.0437 | -74.55% |
| September, 2025 | $4.8941 | $4.264 | $4.9557 | -72.22% |
| October, 2025 | $6.0544 | $4.8142 | $6.3944 | -65.64% |
| November, 2025 | $6.1747 | $5.8045 | $6.5297 | -64.96% |
| December, 2025 | $6.0449 | $5.7449 | $6.4548 | -65.69% |
Cellebrite Di Ltd Stock (CLBT) Price Forecast for 2026
The predicted value for Cellebrite Di Ltd (CLBT) in 2026 is set at an average of $8.9416. Estimates vary from a peak of $12.36 to a trough of $5.5252, indicating an -49.25% surge from the present price of $17.62.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $5.7752 | $5.5551 | $6.2452 | -67.22% |
| February, 2026 | $6.0154 | $5.5252 | $6.2053 | -65.86% |
| March, 2026 | $7.5056 | $5.8155 | $7.5456 | -57.40% |
| April, 2026 | $8.1159 | $7.0357 | $8.1659 | -53.94% |
| May, 2026 | $7.9961 | $7.436 | $8.456 | -54.62% |
| June, 2026 | $7.6964 | $7.4064 | $8.5923 | -56.32% |
| July, 2026 | $7.2567 | $7.2367 | $8.0954 | -58.82% |
| August, 2026 | $7.6669 | $6.6717 | $7.7769 | -56.49% |
| September, 2026 | $8.8572 | $7.6269 | $8.907 | -49.73% |
| October, 2026 | $8.5374 | $8.2573 | $9.1573 | -51.55% |
| November, 2026 | $9.3476 | $8.2175 | $9.8776 | -46.95% |
| December, 2026 | $12.28 | $9.2178 | $12.36 | -30.32% |
Cellebrite Di Ltd Stock (CLBT) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Cellebrite Di Ltd (CLBT) is $8.7558, with a high forecast of $12.81 and a low forecast of $4.7036. This indicates an -50.31% decrease from the last price of $17.62.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $11.83 | $11.56 | $12.81 | -32.87% |
| February, 2027 | $10.78 | $10.59 | $12.49 | -38.83% |
| March, 2027 | $11.27 | $9.6001 | $12.00 | -36.04% |
| April, 2027 | $8.6406 | $8.4005 | $11.07 | -50.96% |
| May, 2027 | $8.621 | $8.261 | $9.4309 | -51.07% |
| June, 2027 | $6.6016 | $5.6715 | $8.9011 | -62.53% |
| July, 2027 | $8.0921 | $6.1317 | $8.9092 | -54.07% |
| August, 2027 | $7.1025 | $6.4325 | $8.2923 | -59.69% |
| September, 2027 | $6.2931 | $6.253 | $8.2326 | -64.28% |
| October, 2027 | $5.7636 | $4.7036 | $6.3932 | -67.29% |
| November, 2027 | $5.614 | $4.9538 | $5.7537 | -68.14% |
| December, 2027 | $5.8546 | $5.0042 | $6.2544 | -66.77% |
Cellebrite Di Ltd Stock (CLBT) Price Forecast for 2028
In 2028, Cellebrite Di Ltd (CLBT) is projected to reach an average price of $5.6203, with a high projection of $6.8343 and a low estimate of $4.4063. This indicates an -68.10% fall from the last price of $17.62.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $5.6551 | $5.6048 | $6.5849 | -67.91% |
| February, 2028 | $5.4055 | $5.1623 | $6.4853 | -69.32% |
| March, 2028 | $4.9061 | $4.6761 | $5.6456 | -72.16% |
| April, 2028 | $5.3665 | $4.4063 | $5.3865 | -69.54% |
| May, 2028 | $5.2271 | $4.9069 | $5.5671 | -70.33% |
| June, 2028 | $4.8976 | $4.6576 | $5.3475 | -72.20% |
| July, 2028 | $5.058 | $4.5679 | $5.258 | -71.29% |
| August, 2028 | $6.1486 | $4.8682 | $6.2086 | -65.10% |
| September, 2028 | $6.7591 | $5.4788 | $6.7591 | -61.64% |
| October, 2028 | $6.4695 | $6.1892 | $6.8343 | -63.28% |
| November, 2028 | $6.0201 | $5.8601 | $6.7596 | -65.83% |
| December, 2028 | $6.4106 | $5.8304 | $6.5503 | -63.62% |
Cellebrite Di Ltd Stock (CLBT) Price Forecast for 2029
The 2029 price forecast for Cellebrite Di Ltd Stock (CLBT) is $9.6084 on average, with a high prediction of $13.12 and a low estimate of $6.1007. This represents an -45.47% decrease from the previous price of $17.62.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $6.9511 | $6.1007 | $7.171 | -60.55% |
| February, 2029 | $8.2216 | $6.8437 | $8.2516 | -53.34% |
| March, 2029 | $8.3121 | $7.7419 | $8.7621 | -52.83% |
| April, 2029 | $8.7925 | $7.9587 | $8.8425 | -50.10% |
| May, 2029 | $8.1931 | $7.7127 | $8.8986 | -53.50% |
| June, 2029 | $7.2936 | $6.9784 | $8.2732 | -58.61% |
| July, 2029 | $9.084 | $7.2538 | $9.214 | -48.44% |
| August, 2029 | $9.3746 | $8.5646 | $9.4046 | -46.80% |
| September, 2029 | $9.145 | $8.525 | $9.4647 | -48.10% |
| October, 2029 | $12.01 | $9.1452 | $12.07 | -31.86% |
| November, 2029 | $12.07 | $11.38 | $13.12 | -31.52% |
| December, 2029 | $12.02 | $11.24 | $12.91 | -31.80% |
Cellebrite Di Ltd Stock (CLBT) Price Forecast for 2030
Cellebrite Di Ltd Stock (CLBT) is expected to reach an average price of $8.6527 in 2030, with a high forecast of $12.30 and a low forecast of $5.0053. This signifies an -50.89% decrease from the last price of $17.62.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $11.47 | $10.89 | $12.05 | -34.91% |
| February, 2030 | $9.5805 | $9.3605 | $12.30 | -45.63% |
| March, 2030 | $9.6412 | $8.631 | $9.7207 | -45.28% |
| April, 2030 | $7.4119 | $7.0919 | $9.7314 | -57.93% |
| May, 2030 | $7.3928 | $5.9722 | $7.7428 | -58.04% |
| June, 2030 | $7.6934 | $7.2929 | $9.2101 | -56.34% |
| July, 2030 | $7.4543 | $6.7338 | $8.534 | -57.69% |
| August, 2030 | $6.255 | $5.745 | $8.2145 | -64.50% |
| September, 2030 | $5.8957 | $5.0053 | $6.5152 | -66.54% |
| October, 2030 | $6.1765 | $5.3064 | $6.5565 | -64.95% |
| November, 2030 | $6.1472 | $5.6967 | $6.8571 | -65.11% |
| December, 2030 | $6.2479 | $5.7878 | $6.8874 | -64.54% |
1.11%
0.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):